Tekla Life Sciences Inves... (HQL)

AI Score

Unlock

11.82

0.16 (1.37%)

At close: Apr 17, 2025, 3:59 PM

11.75

-0.63%

After-hours: Apr 17, 2025, 08:00 PM EDT

Tekla Life Sciences Investors Income Statement

Financials in USD. Fiscal year is October - September.

Fiscal Year	Q4 2024	Q2 2024	Q4 2023	Q2 2023	Q4 2022	Q2 2022	Q4 2021	Q2 2021	Q4 2020	Q2 2020	Q4 2019	Q2 2019	Q4 2018	Q2 2018	Q4 2017	Q2 2017	Q4 2016	Q2 2016
Period Ending	Sep 30, 2024	Mar 31, 2024	Sep 30, 2023	Mar 31, 2023	Sep 30, 2022	Mar 31, 2022	Sep 30, 2021	Mar 31, 2021	Sep 30, 2020	Mar 31, 2020	Sep 30, 2019	Mar 31, 2019	Sep 30, 2018	Mar 31, 2018	Sep 30, 2017	Mar 31, 2017	Sep 30, 2016	Mar 31, 2016
Revenue	1.91M	2.07M	29.56M	1.93M	21.69M	10.17M	15.98M	29.03M	16.5M	22.57M	1.31M	1.13M	988.76K	997.06K	891.49	790.68	721.65	715.56
Cost of Revenue	n/a	n/a	2.59M	n/a	2.64M	2.91M	3.1M	2.97M	2.72M	2.48M	n/a	n/a	n/a	n/a	4.82M	n/a	n/a	n/a
Gross Profit	1.91M	2.07M	26.97M	1.93M	19.05M	7.27M	12.87M	26.06M	13.78M	20.09M	1.31M	1.13M	988.76K	997.06K	-4.82M	790.68	721.65	715.56
Operating Income	-1.27M	-653.34K	-11.45M	-940.75K	-28.31M	-76.3M	32.97M	31.56M	92.87M	30.19M	-1.32M	-1.56M	-1.83M	-1.78M	-2.1K	-1.78K	-1.76K	-2.03K
Interest Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Pretax Income	35.04M	50.26M	-11.45M	33.8M	-28.31M	-76.3M	32.98M	31.55M	92.86M	30.19M	-31.38M	-39.1M	48.41M	-19.74M	41.76K	26.79K	57.38K	-69.29K
Net Income	35.04M	50.26M	-11.45M	33.8M	-28.31M	-76.3M	32.98M	31.55M	92.86M	30.19M	-31.38M	-39.1M	48.41M	-19.74M	41.76K	26.79K	57.38K	-69.29K
Selling & General & Admin	3.18M	2.72M	n/a	2.87M	1.44M	1.56K	1.65K	1.56K	1.43K	1.32K	2.63M	2.69M	2.82M	2.78M	2.99K	2.57K	2.48K	2.75K
Research & Development	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Expenses	n/a	n/a	-38.42M	n/a	-47.35M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	3.18M	2.72M	38.42M	2.87M	14.95M	38.87K	15.9K	15.22K	45.82K	14.01K	2.63M	2.69M	2.82M	2.78M	40.87K	26K	56.66K	70.01K
Interest Expense	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	30.66M	n/a	n/a	n/a	n/a	87.73M	n/a	n/a	n/a
Selling & Marketing Expenses	16.49K	8.11K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	68.45K	n/a	n/a	n/a	n/a	118.58K	n/a	n/a	n/a
Cost & Expenses	3.18M	2.72M	41.01M	2.87M	50M	86.47M	-16.99M	-2.52M	-76.37M	-7.62M	2.63M	2.69M	2.82M	2.78M	40.87K	26K	56.66K	70.01K
Income Tax Expense	n/a	n/a	-43.81K	n/a	-651.14K	-843.92	-1.06K	-1.01K	-825.33	-232.02	n/a	n/a	n/a	n/a	43.86K	28.57K	59.14K	-67.26K
Shares Outstanding (Basic)	28.77M	27.35M	26.79M	26.21M	25.68M	25.14M	24.67M	24.28M	23.75M	23.49M	23.6M	22.76M	22.8M	22.01M	21.57K	21.17K	20.74K	20.12K
Shares Outstanding (Diluted)	28.77M	27.35M	26.79M	26.21M	25.68M	25.14M	24.67M	24.28M	23.75M	23.49M	23.6M	22.76M	22.8M	22.01M	21.57K	21.17K	20.74K	20.12K
EPS (Basic)	1.22	1.84	-0.43	1.29	-1.1	-3.03	1.34	1.30	3.91	1.29	-1.33	-1.72	2.12	-0.9	1.94	1.26	2.76	-3.44
EPS (Diluted)	1.22	1.84	-0.43	1.29	-1.1	-3.03	1.34	1.30	3.91	1.29	-1.33	-1.72	2.12	-0.9	1.94	1.26	2.76	-3.44
EBITDA	n/a	100.51M	-11.45M	n/a	-28.31M	-76.3M	32.97M	31.56M	92.87M	30.19M	n/a	n/a	n/a	n/a	43.86K	28.57K	59.14K	-67.26K
EBIT	-1.27M	100.51M	-11.45M	-940.75K	-28.31M	-76.3M	32.97M	31.56M	92.87M	30.19M	-1.32M	-1.56M	-1.83M	-1.78M	-2.1M	-1.78M	-1.76M	-2.03M
Depreciation & Amortization	1.27M	653.33K	43.81K	940.75K	651.14K	843.92	1.06K	1.01K	825.32	232.02	1.32M	1.56M	1.83M	1.78M	2.1K	1.78K	1.76K	2.03K